Motilal Oswal Alternates sells over 2% stake in Molbio Diagnostics for ₹306 cr
Business Excellence Trust III, a fund of Motilal Oswal Alternates, offloaded 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 apiece
Motilal Oswal Alternates recently divested nearly 2% of its stake in Molbio Diagnostics through open market transactions, selling 23.28 lakh shares of the Goa-based company. The transaction, conducted on Wednesday, generated ₹306.26 crore for the entity, which held an 11.52% stake in Molbio as of August 2026. Business Excellence Trust III, a fund managed by Motilal Oswal Alternates, executed the sale at an average price of ₹1,315.01 per share.
Meanwhile, HDFC Mutual Fund entered the picture by purchasing 23 lakh shares, constituting a 2% stake, for ₹302.45 crore at the same average price. The BSE data did not disclose the identities of the other purchasers. Molbio Diagnostics shares surged 4.07% to close at ₹1,309.45 on the BSE. Earlier this week, Business Excellence Trust III had sold a 2.6% stake in Molbio for ₹394 crore in another bulk deal.
Additionally, Gian Parkash Aggarwal offloaded 15.50 lakh shares, or a 2.71% stake, in pharmaceutical company Innova Captab for ₹167 crore through open market transactions. SBI Mutual Fund acquired a 1.45% stake in Innova Captab by buying 8.33 lakh shares for ₹90 crore. However, Innova Captab shares fell 9% to close at ₹1,158.15 apiece on the BSE.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
